{
    "status": "ok",
    "totalResults": 49,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Neweralive.na"
            },
            "author": "Correspondent",
            "title": "Health ministry scraps middlemen",
            "description": "Lahja Nashuuta\n\n\n\nNamibia\u2019s Ministry of Health and Social Services has eliminated the use of middlemen in procuring medicines and clinical supplies, opting to",
            "url": "https://neweralive.na/health-ministry-scraps-middlemen/",
            "urlToImage": "https://neweralive.na/wp-content/uploads/2025/09/Health-ministry-scaled.jpg",
            "publishedAt": "2025-09-09T11:01:34Z",
            "content": "Lahja Nashuuta\r\nNamibias Ministry of Health and Social Services has eliminated the use of middlemen in procuring medicines and clinical supplies, opting to purchase directly from international manufa\u2026 [+7772 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Precedence Research",
            "title": "Progesterone Market Size Drives at 12.74% CAGR to Hit USD 5.05 Billion by 2034",
            "description": "The global progesterone market is projected to grow from USD 1.72 billion in 2025 to expect USD 5.05 billion by 2034, registering a CAGR of 12.74% over the forecast period. The global progesterone market is projected to grow from USD 1.72 billion in 2025 to e\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/08/3146267/0/en/Progesterone-Market-Size-Drives-at-12-74-CAGR-to-Hit-USD-5-05-Billion-by-2034.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/01eb1f79-0c67-420b-b423-376619f975cd",
            "publishedAt": "2025-09-08T15:00:00Z",
            "content": "Ottawa, Sept. 08, 2025 (GLOBE NEWSWIRE) -- According to a study by Towards Healthcare, a sister firm of Precedence Research, the global\u00a0progesterone market size was valued at USD 1.52 billion in 2024\u2026 [+17592 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Activenoon.com"
            },
            "author": "Jay Jangid",
            "title": "Best Digital Marketing Agencies of India",
            "description": "Digital marketing agencies help businesses to achieve their ROI goals and provide maximum customer satisfaction. Let\u2019s know about some of the leading ones.",
            "url": "https://www.activenoon.com/best-digital-marketing-agencies-of-india/",
            "urlToImage": "https://www.activenoon.com/wp-content/uploads/2025/09/Digital-marketing-Agencies-1.png",
            "publishedAt": "2025-09-08T13:43:09Z",
            "content": "Digital marketing agencies grow the presence of our business by advertising its products, services, or brand on different online platforms, such as search engines, social media, websites, email, and \u2026 [+7397 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Livemint"
            },
            "author": "Priyanka Sharma",
            "title": "Now Sun Pharma, Lupin work on anti-obesity pill to cut costs, address jab aversion",
            "description": "Sun Pharma and Lupin pursue regulatory approval for oral weight-loss drugs, potentially reshaping treatment access.",
            "url": "https://www.livemint.com/companies/now-sun-pharma-lupin-work-on-anti-obesity-pill-to-cut-costs-address-jab-aversion-11757239385114.html",
            "urlToImage": "https://www.livemint.com/lm-img/img/2025/09/07/1600x900/SUN-PHARM-RESULTS--0_1757255629292_1757255644553.JPG",
            "publishedAt": "2025-09-08T00:30:12Z",
            "content": "New Delhi: In a move to address India's obesity crisis, two major pharmaceutical companiesSun Pharma Laboratories Ltd and Lupin Ltdare working to create an affordable anti-obesity pill, according to \u2026 [+4565 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Anupama Ghosh",
            "title": "IT stocks tumble on tariff fears as markets end flat after volatile session",
            "description": "Sensex settled at 80,710.76, down 7.25 points or 0.01%, after touching a high of 81,036.56 during the session; Nifty 50 closed marginally higher at 24,741, up 6.70 points or 0.03%",
            "url": "https://www.thehindubusinessline.com/markets/it-stocks-tumble-on-tariff-fears-as-markets-end-flat-after-volatile-session/article70016258.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/wjpq1g/article70016348.ece/alternates/LANDSCAPE_1200/IMG_PO31_Chart_1_2_1_TAER61OV.jpg",
            "publishedAt": "2025-09-05T13:19:15Z",
            "content": "Markets closed nearly flat on Friday after a highly volatile trading session, with benchmark indices rebounding from early losses as auto stocks surged on GST reforms while information technology sha\u2026 [+4520 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions",
            "description": "The global lyophilized injectable drugs market is set to grow at a 14.0% CAGR from 2025 to 2033, driven by rising demand for stable parenteral medications and expansion in oncology and infectious disease treatments. North America leads, with Asia Pacific expe\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/05/3145153/28124/en/Lyophilized-Injectable-Drugs-Market-Report-2025-2033-R-D-Efforts-to-Improve-Safety-and-Reconstitution-Time-Alongside-Expanding-CDMO-Services-and-Emerging-Market-Contributions.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-05T09:50:00Z",
            "content": "Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The \"Lyophilized Injectable Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and \u2026 [+4844 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva",
            "description": "The Acute Respiratory Distress Syndrome (ARDS) market is projected to grow from $1.32 billion in 2024 to $2.53 billion by 2033, registering a CAGR of 7.51% from 2025 to 2033. Key factors driving this growth include the rise in chronic respiratory diseases, ad\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/04/3144742/28124/en/Acute-Respiratory-Distress-Syndrome-Market-Forecast-and-Company-Analysis-Report-2025-2033-Featuring-Ajanta-Akorn-Alembic-Cipla-Indoco-Remedies-J-J-Novartis-Ocular-Therapeutix-Sun-T.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-04T14:46:00Z",
            "content": "Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The \"Acute Respiratory Distress Syndrome Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033\" report has been added to ResearchAndM\u2026 [+7579 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Alvotech",
            "title": "Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York",
            "description": "REYKJAVIK, Iceland,\u00a0June 4, 2025 - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan Stanley 23rd Annual Global Hea\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/04/3144625/0/en/Alvotech-Meets-Investors-and-Participates-in-a-Fireside-Chat-at-the-Morgan-Stanley-23rd-Annual-Global-Healthcare-Conference-in-New-York.html",
            "urlToImage": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "publishedAt": "2025-09-04T13:15:00Z",
            "content": "REYKJAVIK, Iceland,\u00a0June 4, 2025 - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today it\u2026 [+2840 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Alvotech",
            "title": "Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York",
            "description": "REYKJAVIK, Iceland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan Stanley 23\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/04/3144626/0/en/Alvotech-Meets-Investors-and-Participates-in-a-Fireside-Chat-at-the-Morgan-Stanley-23rd-Annual-Global-Healthcare-Conference-in-New-York.html",
            "urlToImage": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "publishedAt": "2025-09-04T13:15:00Z",
            "content": "REYKJAVIK, Iceland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide\u2026 [+2860 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Raloxifene Hydrochloride Market Analysis Report 2025 | A $3.95 Billion Industry, Reaching $5.7 Billion by 2030 | Regional Healthcare and Supply Chain Trends",
            "description": "The raloxifene hydrochloride market offers opportunities through preventative health applications, particularly in women\u2019s health, with expanding relevance in cancer prevention and bone health. Market segmentation favors cost-effective generics and diverse re\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/04/3144396/28124/en/Raloxifene-Hydrochloride-Market-Analysis-Report-2025-A-3-95-Billion-Industry-Reaching-5-7-Billion-by-2030-Regional-Healthcare-and-Supply-Chain-Trends.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-04T11:36:00Z",
            "content": "Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The \"Raloxifene Hydrochloride Market by Indication (Breast Cancer Risk Reduction, Osteoporosis Prevention), Type (Branded, Generic), Distribution Channel, E\u2026 [+8906 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Yahoo Entertainment"
            },
            "author": "Reuters",
            "title": "Factbox-Global drugmakers rush to boost US presence as tariff threat looms",
            "description": "But with many countries still engaged in trade talks with the U.S., businesses around the world are hedging their decisions pending more clarity on final...",
            "url": "https://finance.yahoo.com/news/factbox-global-drugmakers-rush-boost-180918870.html",
            "urlToImage": "https://media.zenfs.com/en/reuters-finance.com/0a8554c8468466a3849ade6ec5126e66",
            "publishedAt": "2025-09-03T18:09:18Z",
            "content": "(Reuters) -Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump administration weighs hefty tariffs on pharmaceutical imports into the co\u2026 [+5804 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Pazopanib Generics Market Analysis and Forecast 2025-2030: Regional Variances in Regulatory and Reimbursement Frameworks Demand Tailored Market Entry Strategies",
            "description": "Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The \"Pazopanib Generics Market by Application (Ovarian Cancer, Renal Cell Carcinoma, Soft Tissue Sarcoma), Dosage Form (Capsule, Injectable, Tablet), Route Of Administration, Distribution Channel, End User - Global F\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/03/3143349/28124/en/Pazopanib-Generics-Market-Analysis-and-Forecast-2025-2030-Regional-Variances-in-Regulatory-and-Reimbursement-Frameworks-Demand-Tailored-Market-Entry-Strategies.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-03T08:23:00Z",
            "content": "Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The \"Pazopanib Generics Market by Application (Ovarian Cancer, Renal Cell Carcinoma, Soft Tissue Sarcoma), Dosage Form (Capsule, Injectable, Tablet), Route \u2026 [+6895 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Anastrozole APl Market Analysis and Growth Forecast Report 2025-2030 Featuring Profiles of Key Players and Innovations",
            "description": "The Anastrozole API market presents key opportunities through technological innovation, regulatory alignment, and strategic collaborations. Advanced manufacturing and green chemistry enhance efficiency and sustainability, while compliance with evolving regula\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/03/3143348/28124/en/Anastrozole-APl-Market-Analysis-and-Growth-Forecast-Report-2025-2030-Featuring-Profiles-of-Key-Players-and-Innovations.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-03T08:20:00Z",
            "content": "Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The \"Anastrozole APl Market by Generic Status (Branded, Generic), Application (Breast Cancer Treatment, Gynecomastia), Distribution Channel, End User - Glob\u2026 [+8106 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Erlotinib Generics Market Trends and Business Opportunities 2025-2030 - Shift from Branded Erlotinib to Generics Boosts Competition, Access, and Pricing Strategies",
            "description": "Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The \"Erlotinib Generics Market by Application (Non Small Cell Lung Cancer, Pancreatic Cancer), Formulation (Tablet Strength), Distribution Channel, End User - Global Forecast 2025-2030\" has been added to ResearchAndM\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/03/3143346/28124/en/Erlotinib-Generics-Market-Trends-and-Business-Opportunities-2025-2030-Shift-from-Branded-Erlotinib-to-Generics-Boosts-Competition-Access-and-Pricing-Strategies.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-03T08:15:00Z",
            "content": "Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The \"Erlotinib Generics Market by Application (Non Small Cell Lung Cancer, Pancreatic Cancer), Formulation (Tablet Strength), Distribution Channel, End User\u2026 [+7495 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "Anupam Nagar",
            "title": "Markets pin hopes on GST meet as cyclical revival gains traction: Varun Goel",
            "description": "As the GST Council convenes, investors anticipate announcements that could influence market sentiment. Expert Varun Goel predicts FY26 as a potential turning point for India's GDP growth, fueled by monetary easing and tax cuts, benefiting consumption and cape\u2026",
            "url": "https://economictimes.indiatimes.com/markets/stocks/news/markets-pin-hopes-on-gst-meet-as-cyclical-revival-gains-traction-varun-goel/articleshow/123670737.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123670712,width-1200,height-630,imgsize-34412,overlay-etmarkets/articleshow.jpg",
            "publishedAt": "2025-09-03T05:59:29Z",
            "content": "With the crucial GST Council meeting slated for today and tomorrow, investors are bracing for potential announcements that could shape the market mood in the near term. While most rationalisation mea\u2026 [+2074 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Anupama Ghosh",
            "title": "Markets open mixed as GST Council meet begins, gold hits fresh highs",
            "description": "The Sensex opened at 80,295.99 against previous close of 80,157.88 but quickly slipped to 80,052.34, down 105.54 points or 0.13 per cent. The Nifty 50 opened at 24,616.50 versus Monday\u2019s close of 24,579.60 before declining to 24,552.45, losing 27.15 points or\u2026",
            "url": "https://www.thehindubusinessline.com/markets/stock-markets/markets-open-mixed-as-gst-council-meet-begins-gold-hits-fresh-highs/article70006729.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/ty906q/article70006750.ece/alternates/LANDSCAPE_1200/IMG_bl18_p1_GST_2_1_D5DFF769.jpg",
            "publishedAt": "2025-09-03T04:43:11Z",
            "content": "Benchmark indices opened flat to marginally negative on Wednesday morning as investors awaited cues from the crucial two-day GST Council meeting beginning today and key global economic data later thi\u2026 [+4081 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Anupama Ghosh",
            "title": "Sensex tumbles over 700 points from day\u2019s high as banking stocks drag markets lower",
            "description": "Markets close in red as profit booking triggers sharp reversal, with Sensex plunging over 700 points intraday.",
            "url": "https://www.thehindubusinessline.com/markets/sensex-tumbles-over-700-points-from-days-high-as-banking-stocks-drag-markets-lower/article70004120.ece",
            "urlToImage": "https://bl-i.thgim.com/public/todays-paper/tp-others/4ww8mn/article69994586.ece/alternates/LANDSCAPE_1200/PO31_PG4_ALERTSGTAER61P1.4.jpg.jpg",
            "publishedAt": "2025-09-02T13:19:09Z",
            "content": "Markets surrendered early gains to close in the red on Tuesday as profit booking in banking and heavyweight stocks triggered a sharp reversal, with the Sensex plunging over 700 points from its intrad\u2026 [+4320 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SNS Insider pvt ltd",
            "title": "Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates \u2013 SNS Insider",
            "description": "U.S. Leuprolide Acetate Market to Grow from USD 0.88 Billion in 2024 to USD 1.26 Billion by 2032, Driven by Rising Prostate Cancer Incidence and Expanding Adoption in Reproductive Health. U.S. Leuprolide Acetate Market to Grow from USD 0.88 Billion in 2024 to\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/02/3142444/0/en/Leuprolide-Acetate-Market-to-Reach-USD-4-43-Billion-by-2032-as-Demand-for-Hormone-Therapy-Accelerates-SNS-Insider.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2",
            "publishedAt": "2025-09-02T10:30:00Z",
            "content": "Austin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Leuprolide Acetate Market Size &amp; Growth Analysis\r\nAccording to SNS Insider, the Leuprolide Acetate Market size was valued at USD 2.92 billion in 2024 an\u2026 [+10054 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Anupama Ghosh",
            "title": "Markets snap three-day decline as GDP data fuels rally",
            "description": "Nifty 50 gains 198.20 points or 0.81% to close at 24,625.05, while Sensex adds 554.84 points or 0.70% to end at 80,364.49",
            "url": "https://www.thehindubusinessline.com/markets/stock-markets/markets-snap-three-day-decline-as-gdp-data-fuels-rally/article69999861.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/txajog/article69999797.ece/alternates/LANDSCAPE_1200/9245fcfd-da0b-4b8f-a196-dadf2c739bad.jpeg",
            "publishedAt": "2025-09-01T12:49:28Z",
            "content": "Benchmark indices staged a strong recovery on Monday, with the Nifty 50 closing above 24,600 as robust Q1 GDP data of 7.8 per cent boosted investor sentiment and snapped a three-day losing streak. \r\n\u2026 [+4774 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Lyophilized Injectable Drugs Market Report 2025: Emerging Trends, Opportunities, Challenges and Leading Player Growth Strategies",
            "description": "Top Pharma Companies Drive Growth in Lyophilized Injectable Drugs Market with Investments in Freeze-Drying Equipment and Manufacturing Top Pharma Companies Drive Growth in Lyophilized Injectable Drugs Market with Investments in Freeze-Drying Equipment and Man\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/01/3142132/28124/en/Lyophilized-Injectable-Drugs-Market-Report-2025-Emerging-Trends-Opportunities-Challenges-and-Leading-Player-Growth-Strategies.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-01T12:01:00Z",
            "content": "Dublin, Sept. 01, 2025 (GLOBE NEWSWIRE) -- The \"Lyophilized Injectable Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034\" report has been added to ResearchAndM\u2026 [+9253 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Livemint"
            },
            "author": "Priyamvada C, Sneha Shah, Suneera Tandon",
            "title": "Wellbeing Nutrition up for sale: Top FMCG, pharma firms sounded out",
            "description": "The deal could value the company, backed by Hindustan Unilever and Fireside Ventures, at around  \u20b91,500-1,600 crore.",
            "url": "https://www.livemint.com/companies/news/wellbeing-nutrition-acquisition-hindustan-unilever-hul-fireside-ventures-strategic-sale-pharma-companies-fmcg-11756471234640.html",
            "urlToImage": "https://www.livemint.com/lm-img/img/2025/08/29/1600x900/g61c228a264e16fb7700876dab89c5c7dcde9af95cb5524d1a_1749098284944_1756476382740.png",
            "publishedAt": "2025-08-29T14:02:30Z",
            "content": "Wellbeing Nutrition, backed by Hindustan Unilever (HUL) and Fireside Ventures, has been put on the block, with the company likely to see a strategic acquisition. The deal could value the company at a\u2026 [+3824 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SNS Insider pvt ltd",
            "title": "Antiemetics Drugs Market to Hit USD 11.69 Billion by 2032, Driven by Rising Cancer Cases, Chemotherapy Demand, and Breakthrough Formulations \u2013 SNS Insider",
            "description": "SNS Insider Projects U.S. Antiemetics Drugs Market to Surpass USD 3.56 Billion by 2032, Capturing Strong Share Amid Growth in Oncology Care and Gastrointestinal Treatments. SNS Insider Projects U.S. Antiemetics Drugs Market to Surpass USD 3.56 Billion by 2032\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/29/3141515/0/en/Antiemetics-Drugs-Market-to-Hit-USD-11-69-Billion-by-2032-Driven-by-Rising-Cancer-Cases-Chemotherapy-Demand-and-Breakthrough-Formulations-SNS-Insider.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2",
            "publishedAt": "2025-08-29T13:30:00Z",
            "content": "Austin, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Antiemetics Drugs Market Size &amp; Growth Analysis\r\nAccording to SNS Insider, the global Antiemetics Drugs Market was valued at USD 6.73 billion in 2023 and\u2026 [+10025 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "KS Badri Narayanan",
            "title": "Key triggers for these three pharma stocks - Dr Reddy\u2019s Lab, Cipla, Biocon",
            "description": "Dr Reddy's Labs gets stay on tax reassessment, Cipla recalls asthma medication, Biocon gets FDA approval for Sitagliptin tablets.",
            "url": "https://www.thehindubusinessline.com/markets/key-triggers-for-these-three-pharma-stocks-dr-reddys-lab-cipla-biocon/article69983032.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/r2fe1n/article69910824.ece/alternates/LANDSCAPE_1200/IMG_iStock-539372506_2_1_TVCKPQU5.jpg",
            "publishedAt": "2025-08-28T01:29:54Z",
            "content": "Dr Reddys Laboratories has received an interim stay from the Telangana High Court on income tax reassessment proceedings related to its merger with Dr. Reddys Holding Ltd.\u00a0Dr Reddys Laboratories on S\u2026 [+1044 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Ndtvprofit.com"
            },
            "author": "PTI",
            "title": "Cipla Recalls Over 20,000 Packs Of Inhalation Drug In US",
            "description": "Drug major Cipla is recalling over 20,000 packs of a medication, used to treat asthma and certain types of chronic obstructive pulmonary disease, in the US, according to the US health regulator.In its latest Enforcement Report, the US Food and Drug Administra\u2026",
            "url": "https://www.ndtvprofit.com/business/cipla-recalls-over-20000-packs-of-inhalation-drug-in-us",
            "urlToImage": "https://media.assettype.com/bloombergquint%2F2023-08%2Ff85d9861-30a7-419b-b191-0cf1deeffe3d%2FNamesign_of_Cipla_on_stone_plaque_outside_the_company_s_office___image_BloombergQuint__2.jpeg?rect=0%2C38%2C1280%2C672&w=1200&auto=format%2Ccompress&ogImage=true",
            "publishedAt": "2025-08-27T13:32:15Z",
            "content": "Drug major Cipla is recalling over 20,000 packs of a medication, used to treat asthma and certain types of chronic obstructive pulmonary disease, in the US, according to the US health regulator."
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "PTI",
            "title": "Cipla recalls over 20k packs of inhalation drug in US",
            "description": "In its latest Enforcement Report, the US Food and Drug Administration (USFDA) states that Cipla USA, Inc., an arm of the Mumbai-based drug major, is recalling Ibuterol Sulfate Inhalation Aerosol",
            "url": "https://www.thehindubusinessline.com/companies/cipla-recalls-over-20k-packs-of-inhalation-drug-in-us/article69982442.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/w0li7g/article69854427.ece/alternates/LANDSCAPE_1200/IMG_Cipla_photograph_1.j_2_1_HJD9JO3M.jpg",
            "publishedAt": "2025-08-27T11:23:25Z",
            "content": "Drug major Cipla is recalling over 20,000 packs of a medication, used to treat asthma and certain types of chronic obstructive pulmonary disease, in the US, according to the US health regulator.\r\nIn \u2026 [+887 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Yahoo Entertainment"
            },
            "author": "Sheryl Estrada",
            "title": "Keurig Dr Pepper CFO\u2019s leap to CEO of coffee spinoff fueled by key career moves",
            "description": "KDP will split into two U.S.-listed companies following its acquisition of JDE Peet\u2019s.",
            "url": "https://finance.yahoo.com/news/keurig-dr-pepper-cfo-leap-122147478.html",
            "urlToImage": "https://s.yimg.com/ny/api/res/1.2/Z9817S5tw3I_2AyZZ.LnUw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/fortune_175/51efb42d84ef35195c865a93a02313ec",
            "publishedAt": "2025-08-26T12:21:47Z",
            "content": "Good morning. In less than three years, Sudhanshu Priyadarshi, CFO of Keurig Dr Pepper (KDP), was tapped for a chief executive role.\r\nKDP announced on Monday an agreement to acquire Amsterdam-based c\u2026 [+2725 chars]"
        },
        {
            "source": {
                "id": "fortune",
                "name": "Fortune"
            },
            "author": "Sheryl Estrada",
            "title": "Keurig Dr Pepper CFO\u2019s leap to CEO of coffee spinoff fueled by key career moves",
            "description": "KDP will split into two U.S.-listed companies following its acquisition of JDE Peet\u2019s.",
            "url": "https://fortune.com/2025/08/26/keurig-dr-pepper-cfo-leap-ceo-coffee-spinoff-fueled-key-career-moves/",
            "urlToImage": "https://fortune.com/img-assets/wp-content/uploads/2025/08/Sudhanshu-Priyadarshi-Keurig.jpg?resize=1200,600",
            "publishedAt": "2025-08-26T12:21:47Z",
            "content": "Good morning. In less than three years, Sudhanshu Priyadarshi, CFO of Keurig Dr Pepper (KDP), was tapped for a chief executive role.KDP announced on Monday an agreement to acquire Amsterdam-based cof\u2026 [+6607 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Livemint"
            },
            "author": "Jessica Jani",
            "title": "Mint Explainer | First Dr Reddy\u2019s, now Natco: Why Indian drugmakers are suing Novo Nordisk",
            "description": "As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The lawsuits could pave the way for cheaper generics, catering to India's vast population battling obesity.&nbsp;",
            "url": "https://www.livemint.com/companies/dr-reddy-s-natco-indian-drugmakers-novo-nordisk-patent-lawsuits-weight-loss-drugs-wegovy-ozempic-generic-drugs-11756124743725.html",
            "urlToImage": "https://www.livemint.com/lm-img/img/2025/08/25/1600x900/INDIA-WEGOVY-6_1751614661405_1751614669024_1756126241653.jpg",
            "publishedAt": "2025-08-25T13:03:18Z",
            "content": "Two Indian drugmakers have filed lawsuits against Danish drugmaker Novo Nordisk over its blockbuster weight-loss drug semaglutide, which is set to lose its patent in India in March 2026. With just ab\u2026 [+4426 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Economictimes.com"
            },
            "author": "ETMarkets.com",
            "title": "Stocks to Buy | Top Trading Ideas: Cipla & Maruti for near-term rally",
            "description": "Nifty is expected to trade in a 24,800\u201325,000 range amid consolidation, while Bank Nifty shows weakness below 55,500. The auto sector remains strong, led by Hero MotoCorp, Bajaj Auto, Maruti and more.",
            "url": "https://m.economictimes.com/markets/stocks/news/stocks-to-buy-top-trading-ideas-cipla-amp-maruti-for-near-term-rally/market-overview/slideshow/123499298.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123499298,width-1070,height-580,overlay-etmarkets/slideshow.jpg",
            "publishedAt": "2025-08-25T08:39:27Z",
            "content": "Aug 25, 2025, 02:18:37 PM IST\r\nRajesh Palviya, in an interview with ET Now, said that Nifty is expected to remain in the range of 24,800\u201325,000 over the next few days.\r\nRajesh Palviya notes that as w\u2026 [+2688 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Ndtvprofit.com"
            },
            "author": "Ann Jacob",
            "title": "Stock Picks Today: ITC Hotels, Bajaj Finance, Cipla, Trent, Lemon Tree On Brokerages' Radar",
            "description": "ITC Hotels Ltd., Bajaj Finance Ltd., Cipla Ltd., Trent Ltd., and Lemon Tree Hotels Ltd. are among the companies garnering brokerages' commentary today. Analysts have shared their insights and, in several cases, revised their target prices based on their updat\u2026",
            "url": "https://www.ndtvprofit.com/markets/stock-picks-today-itc-hotels-bajaj-finance-cipla-trent-lemon-tree-on-brokerages-radar",
            "urlToImage": "https://media.assettype.com/bloombergquint%2F2025-08-25%2Fnfz0zu76%2Fyoung-businessman-financial-market-analyst-sits-at-2025-01-10-15-03-26-utc.jpg?w=1200&auto=format%2Ccompress&ogImage=true",
            "publishedAt": "2025-08-25T02:22:35Z",
            "content": "ITC Hotels Ltd., Bajaj Finance Ltd., Cipla Ltd., Trent Ltd., and Lemon Tree Hotels Ltd. are among the companies garnering brokerages' commentary today. \r\nAnalysts have shared their insights and, in s\u2026 [+101 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "PT Jyothi Datta",
            "title": "Pharma\u2019s pursuit of growth: Knocking on consumer doors",
            "description": "Pharma companies are separating consumer healthcare businesses to drive growth, facing challenges in a competitive market.",
            "url": "https://www.thehindubusinessline.com/specials/pulse/pharma-companies-are-separating-consumer-healthcare-businesses-to-drive-growth-facing-challenges-in-a-competitive-market/article69967939.ece",
            "urlToImage": "https://bl-i.thgim.com/public/news/egybej/article69971651.ece/alternates/LANDSCAPE_1200/BL2508_Pulse_Lead.jpg",
            "publishedAt": "2025-08-25T01:00:00Z",
            "content": "Drugmakers are lining up to carve out their consumer healthcare businesses, and benefit from knocking directly on consumer doors, in a sense despite their styles being diametrically different, like c\u2026 [+4594 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Akhil Nallamuthu",
            "title": "Movers & Shakers: Stocks that will see action this week",
            "description": "Stock analysis: Samvardhana Motherson International bearish, SJVN bullish, Cipla breaks resistance; trading strategies and price targets provided.",
            "url": "https://www.thehindubusinessline.com/portfolio/technical-analysis/movers-shakers-stocks-that-will-see-action-this-week/article69969139.ece",
            "urlToImage": "https://bl-i.thgim.com/public/news/fffo49/article66069767.ece/alternates/LANDSCAPE_1200/stock%20market%2002136.jpg",
            "publishedAt": "2025-08-23T16:09:38Z",
            "content": "Samvardhana Motherson International (95.17)\r\nBears have the upper hand\r\nThe stock of Samvardhana Motherson International, after facing a resistance at 106 in June, started to fall and ended the\u00a0corre\u2026 [+1619 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "ET Now",
            "title": "2 top stock recommendations from Rajesh Palviya for next week",
            "description": "Entering the August expiry week, Nifty faces a supply zone at 25,000\u201325,200, with potential consolidation above 24,800. Bank Nifty appears weaker, needing to surpass 55,500 to avoid further decline. Auto stocks, particularly Hero MotoCorp, Bajaj Auto, and Mar\u2026",
            "url": "https://economictimes.indiatimes.com/markets/expert-view/2-top-stock-recommendations-from-rajesh-palviya-for-next-week/articleshow/123467458.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123467450,width-1200,height-630,imgsize-21166,overlay-etmarkets/articleshow.jpg",
            "publishedAt": "2025-08-23T06:49:59Z",
            "content": "\"Now, as we enter the August series expiry week, 25,00025,200 is likely to act as a major supply zone. On the downside, if we are able to sustain above 24,800, then some consolidation could happen at\u2026 [+4799 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Precedence Research",
            "title": "Over the Counter Drugs (OTC) Market Size Worth USD 242.94 Billion by 2034 Driven by Self-Care and E-Commerce Expansion",
            "description": "The global over the counter (OTC) drugs market size was valued at USD 129.80 billion in 2024 and is expected to grow at a CAGR of 6.72% from 2025 to 2034, reaching approximately USD 242.94 billion by 2034. Market growth is fueled by the rising adoption of sel\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/22/3137775/0/en/Over-the-Counter-Drugs-OTC-Market-Size-Worth-USD-242-94-Billion-by-2034-Driven-by-Self-Care-and-E-Commerce-Expansion.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/01eb1f79-0c67-420b-b423-376619f975cd",
            "publishedAt": "2025-08-22T11:24:00Z",
            "content": "Ottawa, Aug. 22, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the\u00a0global over the counter (OTC) drugs market size is expected to be worth over USD 242.94 billion by 2034, up from USD 13\u2026 [+21704 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "ET Now",
            "title": "Global noise may create volatility, but domestic macros remain strong: Rahul Shah",
            "description": "Rahul Shah of MOFSL suggests a stock-specific market approach, highlighting cement, banks, and metals as promising sectors. He anticipates continued growth in these areas, driven by domestic demand and government initiatives. While global events may cause vol\u2026",
            "url": "https://economictimes.indiatimes.com/markets/expert-view/global-noise-may-create-volatility-but-domestic-macro-remains-strong-rahul-shah/articleshow/123449449.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123449453,width-1200,height-630,imgsize-20278,overlay-etmarkets/articleshow.jpg",
            "publishedAt": "2025-08-22T07:50:59Z",
            "content": "\"Banks are another strong pocket. ICICI, State Bank, and HDFC have all reported blockbuster numbers, and I believe they will continue to do well. Metals too, especially steel, should rebound after th\u2026 [+5081 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "ET Now",
            "title": "How can businesses like Swiggy, Eternal, Honasa and PB Fintech benefit from reduced GST? Sunny Agrawal answers",
            "description": "Sunny Agrawal anticipates GST rationalization to significantly boost consumption, benefiting sectors like auto, real estate, and new-age businesses such as food delivery services. While the pharma sector faces potential US tariff headwinds, CDMO companies and\u2026",
            "url": "https://economictimes.indiatimes.com/markets/expert-view/how-can-businesses-like-swiggy-eternal-honasa-and-pb-fintech-benefit-from-reduced-gst-sunny-agrawal-answers/articleshow/123446298.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123446573,width-1200,height-630,imgsize-25164,overlay-etmarkets/articleshow.jpg",
            "publishedAt": "2025-08-22T05:23:53Z",
            "content": "Sunny Agrawal, Head- Fundamental Equity Research, SBI Cap Securities, says GST rationalisation is expected to boost consumption. This also benefits food delivery companies and consumer brands. Reduct\u2026 [+3551 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "Nikhil Agarwal",
            "title": "Q1 results led to Asia\u2019s biggest downgrades but 5 brokerages have over 90 stocks in buying list",
            "description": "Despite earlier earnings downgrades, brokerages anticipate a rebound in India Inc's earnings, potentially reaching double-digits after five quarters, fueled by a low base and early Diwali. Opportunities are seen in domestic-focused sectors like financials and\u2026",
            "url": "https://economictimes.indiatimes.com/markets/stocks/news/q1-results-led-to-asias-biggest-downgrades-but-5-brokerages-have-over-90-stocks-in-buying-list/articleshow/123444557.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123444538,width-1200,height-630,imgsize-46266,overlay-etmarkets/articleshow.jpg",
            "publishedAt": "2025-08-22T03:30:46Z",
            "content": "Even as India Inc saw Asia's biggest earnings downgrades after a modest Q1 and amid risks from steep US tariffs, brokerages say weak earnings cycle may have bottomed out. Not only will the consumptio\u2026 [+3544 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Lokmattimes.com"
            },
            "author": "Ani",
            "title": "Indian stock market ends higher on hopes of GST rate cut, rises for 6th straight session - www.lokmattimes.com",
            "description": "Indian stock market ends higher on hopes of GST rate cut, rises for 6th straight session - Mumbai (Maharashtra) [India], August 21 : The Indian stock market on Thursday ended higher on the sixth consecutive session ... - Latest News. Find Breaking Headlines, \u2026",
            "url": "https://www.lokmattimes.com/business/indian-stock-market-ends-higher-on-hopes-of-gst-rate-cut-rises-for-6th-straight-session/",
            "urlToImage": "https://d3pc1xvrcw35tl.cloudfront.net/ln/feedImages/1200x900/ANI-20250821104809_202508.jpg",
            "publishedAt": "2025-08-22T02:15:20Z",
            "content": "Mumbai (Maharashtra) [India], August 21 : The Indian stock market on Thursday ended higher on the sixth consecutive session as investors' sentiments are optimistic due to the possible Goods and Servi\u2026 [+3095 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SNS Insider pvt ltd",
            "title": "Dementia Treatment Market Size to Surpass USD 33.54 Billion by 2032, Fueled by Breakthrough Therapies and Growing Patient Awareness \u2013 SNS Insider",
            "description": "SNS Insider Highlights U.S. Dementia Treatment Market Growth, Valued at USD 5.35 Billion in 2023, Poised to Reach USD 10.50 Billion by 2032, Driven by Aging Population and Advancements in Precision Medicine. SNS Insider Highlights U.S. Dementia Treatment Mark\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/21/3137231/0/en/Dementia-Treatment-Market-Size-to-Surpass-USD-33-54-Billion-by-2032-Fueled-by-Breakthrough-Therapies-and-Growing-Patient-Awareness-SNS-Insider.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2",
            "publishedAt": "2025-08-21T13:30:00Z",
            "content": "Austin, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Dementia Treatment Market Size &amp; Growth Outlook\r\nAccording to SNS Insider, the global Dementia Treatment Market was valued at USD 17.06 billion in 2023 a\u2026 [+8634 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Alvotech",
            "title": "Advanz Pharma and Alvotech receive European approval for Mynzepli\u00ae, Biosimilar to Eylea\u00ae",
            "description": "REYKJAVIK, Iceland and LONDON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (\u201cAdvanz Pharma\u201d\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/21/3136921/0/en/Advanz-Pharma-and-Alvotech-receive-European-approval-for-Mynzepli-Biosimilar-to-Eylea.html",
            "urlToImage": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "publishedAt": "2025-08-21T08:30:00Z",
            "content": "<ul><li>Mynzepli\u00ae (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (\u2026 [+15387 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Alvotech",
            "title": "Advanz Pharma and Alvotech receive European approval for Mynzepli\u00ae, Biosimilar to Eylea\u00ae",
            "description": "REYKJAVIK, ICELAND and LONDON, UK (August 21, 2025) \u2014 Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (\u201cAdvanz Pharma\u201d), a UK hea\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/21/3136919/0/en/Advanz-Pharma-and-Alvotech-receive-European-approval-for-Mynzepli-Biosimilar-to-Eylea.html",
            "urlToImage": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "publishedAt": "2025-08-21T08:30:00Z",
            "content": "<ul><li>Mynzepli\u00ae (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (\u2026 [+15385 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Anupama Ghosh",
            "title": "Sensex gains 296 points as markets extend winning run to fifth session",
            "description": "Markets maintained their upward trajectory for the fifth consecutive session on Thursday afternoon, with the Sensex trading 295.58 points higher at 82,153.42 and the Nifty gaining 72.90 points to reach 25,123.45 as of 12.45 PM.",
            "url": "https://www.thehindubusinessline.com/markets/stock-markets/sensex-gains-296-points-as-markets-extend-winning-run-to-fifth-session/article69959352.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/tg4r1g/article69959383.ece/alternates/LANDSCAPE_1200/2025-07-04T063922Z_1738931305_RC2USDAZDY5T_RTRMADP_3_INDIA-BROKERS-STOCKS-JANE-STREET.JPG",
            "publishedAt": "2025-08-21T07:45:35Z",
            "content": "Markets maintained their upward trajectory for the fifth consecutive session on Thursday afternoon, with the Sensex trading 295.58 points higher at 82,153.42 and the Nifty gaining 72.90 points to rea\u2026 [+2244 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Alvotech",
            "title": "Alvotech appoints Patrik Ling as VP of Investor Relations Scandinavia",
            "description": "REYKJAVIK,\u00a0ICELAND (August 20, 2025) \u2014 Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Patrik Ling has joined the company as VP Investor Rel\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/20/3136263/0/en/Alvotech-appoints-Patrik-Ling-as-VP-of-Investor-Relations-Scandinavia.html",
            "urlToImage": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "publishedAt": "2025-08-20T10:05:00Z",
            "content": "REYKJAVIK,\u00a0ICELAND (August 20, 2025) Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced \u2026 [+3858 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Anupama Ghosh",
            "title": "Nifty crosses 25,000 mark before closing lower as markets extend fourth straight rally",
            "description": "Auto stocks gained momentum as China lifted export restrictions on rare earth magnets. \u201cStocks like Tata Motors, Bajaj Auto saw renewed strength after reports of easing supply restrictions,\u201d said Hariprasad K, Founder at Livelong Wealth.",
            "url": "https://www.thehindubusinessline.com/markets/stock-markets/nifty-crosses-25000-mark-before-closing-lower-as-markets-extend-fourth-straight-rally/article69951689.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/7ywr1n/article69951844.ece/alternates/LANDSCAPE_1200/PO09_Growth_chart_arrow.jpg",
            "publishedAt": "2025-08-19T12:54:03Z",
            "content": "Markets on Tuesday extended their winning streak for the fourth consecutive session, with benchmark indices closing in positive territory driven by strong sectoral performance and GST reform optimism\u2026 [+2640 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "BL Hyderabad Bureau",
            "title": "ISB Dean Madan Pillutla, ex-Deloitte India Chairman P R Ramesh join Cyient board",
            "description": "Experienced professionals Pillutla and Ramesh join Cyient as Independent Directors, bringing expertise from top companies and institutions.",
            "url": "https://www.thehindubusinessline.com/info-tech/isb-dean-madan-pillutla-ex-deloitte-india-chairman-p-r-ramesh-join-cyient-board/article69950759.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/eijta7/article69950817.ece/alternates/LANDSCAPE_1200/IMG_PO09_business_2_1_SPB3689N.jpg",
            "publishedAt": "2025-08-19T08:19:23Z",
            "content": "Former Deloitte India Chairman P R Ramesh and Indian School of Business Dean Madan Pillutla have joined as Independent Directors on the Board of Cyient, an intelligent engineering solutions company.\r\u2026 [+634 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "ET Now",
            "title": "FMCG in a sweet spot after GST cuts and monsoon boost: Rajat Sharma",
            "description": "Markets are positive due to GST bonanza. Rajat Sharma of Sana Securities highlights FMCG's sweet spot, driven by revised tax rates and good monsoons. Pharma sector is also attractive due to lack of tariffs and India's strong position in generics supply to the\u2026",
            "url": "https://economictimes.indiatimes.com/markets/expert-view/fmcg-in-a-sweet-spot-after-gst-cuts-and-monsoon-boost-rajat-sharma/articleshow/123378150.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123378151,width-1200,height-630,imgsize-23144,overlay-etmarkets/articleshow.jpg",
            "publishedAt": "2025-08-19T04:56:29Z",
            "content": "\"For disclosure, HUL and Asian Paints have been my top picks since the beginning of this year, and I have mentioned this on your channel before. The slowdown in consumption had been so severe that a \u2026 [+4569 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "Charmy Harikrishnan and Teena Thacker",
            "title": "Food Chained: How weight-loss drugs are changing India\u2019s eating habits and forcing restaurants to take note",
            "description": "New diabetes and obesity drugs, like Mounjaro and Ozempic, are changing people's relationships with food. While these drugs help control diabetes and promote weight loss by altering taste and reducing hunger, some users experience a loss of enjoyment in eatin\u2026",
            "url": "https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/food-chained-how-weight-loss-drugs-are-changing-indias-eating-habits-and-forcing-restaurants-to-take-note/articleshow/123341779.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123341883,width-1200,height-630,imgsize-1661938,overlay-economictimes/articleshow.jpg",
            "publishedAt": "2025-08-17T03:40:51Z",
            "content": "Rakesh Goyal, a businessman in East Delhi, cant bear to look at chhole-bhature any longer. It was his favourite food, the Sunday lunch he looked forward to, but one day his taste changed. I dont want\u2026 [+9883 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "The BMJ"
            },
            "author": "Mathioudakis, A. G., Higham, A., Bate, S., Chatzimavridou-Grigoriadou, V., Sivapalan, P., Jensen, J.-U. S., Felton, T., Vestbo, J., Singh, D.",
            "title": "Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial",
            "description": "Inhaled corticosteroids (ICSs) benefit patients with chronic obstructive pulmonary disease at high risk of exacerbations with raised blood eosinophil count (BEC). Emerging evidence suggests current smokers show a reduced response to ICS. This post-hoc analysi\u2026",
            "url": "https://thorax.bmj.com/content/80/9/658",
            "urlToImage": "https://thorax.bmj.com/sites/default/files/highwire/thoraxjnl/80/9.cover-source.jpg",
            "publishedAt": "2025-08-15T14:42:36Z",
            "content": "<li>X @mathioudakisag\r\n</li><li>Contributors Guarantor: AGM. Study Conception: AGM, AH, JV, DS. Study design: AGM, AH, JV, DS. Statistical analysis: AGM, SB. Interpretation of findings: All authors. \u2026 [+1964 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Livemint"
            },
            "author": "list.metadata.agency",
            "title": "Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost",
            "description": "Union Commerce and Industry Minister Piyush Goyal has discussed strategies to boost competitiveness and strengthen research and development activities with the business representatives of the pharmaceutical industry.",
            "url": "https://www.livemint.com/companies/news/piyush-goyal-meets-pharma-industry-leaders-to-discuss-r-d-competitiveness-boost-11755225458917.html",
            "urlToImage": "https://www.livemint.com/lm-img/img/2024/12/06/1600x900/company_4_1733465206851_1733465215415.png",
            "publishedAt": "2025-08-15T02:37:38Z",
            "content": "New Delhi [India], August 15 (ANI): Union Commerce and Industry Minister Piyush Goyal has discussed strategies to boost competitiveness and strengthen research and development activities with the bus\u2026 [+2052 chars]"
        }
    ]
}